EPAT SHOCKWAVE THERAPY

ABOUT Extracorporeal Pulse Activation Technology (EPAT)

Extracorporeal Pulse Activation Technology (EPAT) is a non-invasive therapy option for acute and chronic pain. High-energy shockwaves are focused onto the affected area to stimulate the speed up of the body’s own healing process. EPAT can over-stimulate nerves which reduces sensitivity and pain in the area.

It is one of the most advanced and highly effective noninvasive therapy methods approved by the FDA for conditions that are treatable. The therapy works by helping to improve the regenerative potential, enhancing blood circulation to regenerate damaged tissue which can eliminate/reduce pain, accelerate healing, and restore mobility, thus improving patients’ quality of life. Beneficial effects are often experienced after only 1 or 2 treatments and there is little or no downtime. 

BENEFITS OF EPAT

• Non-Surgical 
• No Side Effects 
• Accelerated Healing 
• Ease of Use 
• Affordable
• 91% Success Rate
• Non-invasive
• No Anesthesia Required
• No Risk of Infection
• No Scarring
• No Downtime
• Over 80% Patient Satisfaction
• Faster, Easier Healing

SUCCESS RATES OF EPAT

• 91% improvement for shoulder pain (Journal of American Medical Association, 2003)
• 90% success rate for heel pain (Foot & Ankle International, 2012)
• 77% improvement for elbow pain (The Journal of Orthopaedics, 2005)
• 76% success rate for achilles pain (The American Journal of Sports Medicine, 2007)
• 8 times more effective for hamstring pain than regular Physiotherapy and Chiropractic treatment (The American Journal of Sports Medicine, 2010)

CONDITIONS THAT CAN BE TREATED BY EPAT

• Achilles Pain
• Anterior Shin Pain
• Back & Hip Pain
• Carpel Tunnel Syndrome
• Elbow Pain (Tennis & Golfer's Elbow)
• Foot Pain & Plantar Fasciitis
• Hamstring Pain & Issues
• Knee Pain
• Muscle Pain and Connective Tissue
• Neck Pain
• Pain Relief 
• Posterior Heel Pain
• Scar Tissue Treatment
• Shin Pain & Splints
• Shoulder Pain & Frozen Shoulder
• Stress Fractures
• Toe Pain

Extracorporeal Pulse Activation Technique (EPAT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved Storz D-Actor 100 device to administer ESWT.

The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.